Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Barnet-Dulaney-Perkins-Eye-Center"

1 News Found

FDA approves Roche’s Susvimo as the first and only continuous delivery treatment diabetes-related blindness
Drug Approval | February 05, 2025

FDA approves Roche’s Susvimo as the first and only continuous delivery treatment diabetes-related blindness

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)